The development and increasing adoption of minimally invasive and uterus-sparing alternatives have significantly impacted Hysterectomy Rates for uterine fibroids. Historically, hysterectomy—the complete removal of the uterus—was the most common definitive surgical procedure for symptomatic disease. However, the rise of effective treatments like Uterine Fibroid Embolization (UFE), advanced hysteroscopic myomectomy, and high-intensity focused ultrasound (HIFU) now provide women with alternatives that resolve symptoms while preserving the organ.

While UFE is a potent non-surgical alternative, it is not always a permanent solution for all patients. Studies show that patients who undergo UFE have a subsequent hysterectomy rate that is higher than those who undergo myomectomy over a five-year period, as some women experience persistent symptoms or develop new fibroids that require definitive treatment. Nonetheless, the widespread availability of less invasive options has successfully transformed the treatment algorithm, reserving hysterectomy primarily for women who have completed childbearing and wish for a guaranteed, permanent cessation of symptoms.

Related Reports